Product Details:
| Minimum Order Quantity | 5 Bottle |
| Packaging Size | 60 Tablets |
| Brand | Lopimune 200/50 mg |
| Manufacturer | Cipla Ltd |
| Composition | Lopinavir and Ritonavir |
| Treatment | HIV |
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Shelf life | 2 Years |
LOPIMUNE is a combination of lopinavir and ritonavir. Lopinavir is an inhibitor of the HIV-1 protease.
Lopimune tablets 200/50mg are a fixed dose combination treatment for Human Immunodeficiency Virus (HIV) infection in adults over and children over 6 months. Lopimune tablets200/50mg are used in combination with other medications that have a different mechanism of action to the components in Lopimune, and are used to treat patients with HIV infection who have either already received treatment with other medications for HIV or as first line therapy for treatment-inexperienced patients. HIV impairs the immune system by attacking specific immune cells called CD4+ cells that are involved in fighting infection and this can lead to opportunistic life-threatening infection (infections that would not normally be harmful); also if too many CD4+ cells are destroyed this can result in acquired immune deficiency syndrome (AIDS). Lopimune tablets prevent or slow down the ability of HIV to replicate and spread, which keeps the amount virus down to a low level and this results in an increase in CD4+ cell numbers, so that the immune system can recover, reducing the risk of disease progression.
Lopimune tablets 200/50mg contain a combination of the active ingredients lopinavir (200mg) and ritonavir (50mg), which are antiretroviral drugs that are used to treat HIV infection by inhibition of HIV protease.
Additional Information:
- Delivery Time: 10 to 15 Days (Depending on the destination country)
